Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495305 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL493797 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL495782 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL496560 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL494972 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL494426 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL494384 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL495527 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL495112 | 0.98 | KMT2A (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT | |
| SCHEMBL9510213 | 0.94 | CYP1A2 (0.53) | CYP1A2KMT2APOLBL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2418030-B1 | CURING AGENT COMPOSITION | KAO CORP (JP) | 2019-09-25 | — | — | EP | claimed |
| US-20120043694-A1 | CURING AGENT COMPOSITION | KAO CORPORATION (JP) | 2012-02-23 | — | — | US | claimed |
| EP-2418030-A1 | CURING AGENT COMPOSITION | Kao Corporation (JP) | 2012-02-15 | — | — | EP | claimed |
| EP-2418030-B1 | CURING AGENT COMPOSITION | KAO CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| EP-2581148-B1 | PROCESS FOR PRODUCTION OF MOLDS | KAO CORP (JP) | 2018-10-24 | — | — | EP | disclosed |
| US-8729152-B2 | Curing agent composition | KAO CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| EP-2287147-B1 | 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | TAISHO PHARMACEUTICAL CO LTD (JP) | 2013-05-15 | — | — | EP | disclosed |
| EP-2581148-A1 | PROCESS FOR PRODUCTION OF MOLDS | Kao Corporation (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-20120261087-A1 | PROCESS FOR PRODUCING A MOLD | KAO CORPORTATION (JP) | 2012-10-18 | — | — | US | disclosed |
| EP-2123630-B1 | 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | TAISHO PHARMACEUTICAL CO LTD (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120043694-A1 | CURING AGENT COMPOSITION | KAO CORPORATION (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-2418030-A1 | CURING AGENT COMPOSITION | Kao Corporation (JP) | 2012-02-15 | — | — | EP | disclosed |
| EP-2287147-A2 | 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | Taisho Pharmaceutical Co., Ltd. (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-1637517-B1 | 2-AMINOBICYCLO 3.1.0 HEXANE-2,6-DICARBOXYLIC ESTER DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-2123630-A1 | 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative | Taisho Pharmaceutical Co. Ltd. (JP) | 2009-11-25 | — | — | EP | disclosed |
| EP-1637517-A1 | 2-AMINOBICYCLO 3.1.0 HEXANE-2,6-DICARBOXYLIC ESTER DERIVATIVE | Taisho Pharmaceutical Co. Ltd. (JP) | 2006-03-22 | — | — | EP | disclosed |
| EP-1370519-A1 | SYNTHETIC EXCITATORY AMINO ACIDS | ELI LILLY AND COMPANY (US) | 2003-12-17 | — | — | EP | disclosed |
| WO-2002068380-A1 | SYNTHETIC EXCITATORY AMINO ACIDS | ELI LILLY AND COMPANY (US) | 2002-09-06 | — | — | WO | disclosed |
| CN-1066135-C | Ysnthetic excitatory amino acids | LILLY CO ELI (US) | 2001-05-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043694-A1 | CURING AGENT COMPOSITION | ERG28, SMARCA5, MYB | CYP1A2 1281/4885KMT2A 465/4885POLB 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.